U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry RACEMIC
Molecular Formula C8H11NO2.ClH
Molecular Weight 189.639
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NORFENEFRINE HYDROCHLORIDE

SMILES

Cl.NCC(O)C1=CC=CC(O)=C1

InChI

InChIKey=OWMFSWZUAWKDRR-UHFFFAOYSA-N
InChI=1S/C8H11NO2.ClH/c9-5-8(11)6-2-1-3-7(10)4-6;/h1-4,8,10-11H,5,9H2;1H

HIDE SMILES / InChI

Description

Norfenefrine or meta-octopamine, also known as 3,β-dihydroxyphenethylamine, is an adrenergic agent used as a sympathomimetic drug which is marketed in Europe, Japan, and Mexico. Along with its structural isomer p-octopamine and the tyramines, norfenefrine is a naturally occurring, endogenous trace amine and plays a role as a minor neurotransmitter in the brain. Norfenefrine controls blood pressure in acute hypotensive states eg pheochromocytomectomy, sympathectomy, poliomyelitis, spinal anesth, MI, septicemia, blood transfusion and drug reactions. Adjunct in treatment of cardiac arrest and hypotension.

CNS Activity

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown
Primary
Nevadral Retard

Doses

AEs

PubMed

Sample Use Guides

In Vivo Use Guide
For the treatment of female stress incontinence 60 mg were given in slow-release tablets.
Route of Administration: Oral
In Vitro Use Guide
At 0.1 and 1 umol/l, norfenefrine caused contractions of the rabbit pulmonary artery strips